ING Groep NV Has $38.83 Million Stock Holdings in Danaher Corporation $DHR

ING Groep NV decreased its holdings in Danaher Corporation (NYSE:DHR) by 51.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 169,604 shares of the conglomerate’s stock after selling 181,382 shares during the quarter. ING Groep NV’s holdings in Danaher were worth $38,826,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at $26,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter valued at $25,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the third quarter valued at $27,000. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Danaher during the fourth quarter valued at $33,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DHR. TD Cowen cut their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Wells Fargo & Company cut their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Finally, UBS Group cut their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $235.14.

Danaher Stock Performance

Shares of NYSE:DHR opened at $184.45 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market cap of $130.55 billion, a PE ratio of 35.68, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The business has a fifty day moving average of $181.29 and a 200-day moving average of $206.19.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company posted $1.88 earnings per share. On average, equities research analysts predict that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.